Radioactive main group and rare earth metals for imaging and therapy
Radiometals possess an exceptional breadth of decay properties and have been applied to
medicine with great success for several decades. The majority of current clinical use …
medicine with great success for several decades. The majority of current clinical use …
Matching chelators to radiometals for radiopharmaceuticals
Radiometals comprise many useful radioactive isotopes of various metallic elements. When
properly harnessed, these have valuable emission properties that can be used for …
properly harnessed, these have valuable emission properties that can be used for …
Remarkable potential of the α-aminophosphonate/phosphinate structural motif in medicinal chemistry
R-Aminophosphonic acids are broadly defined as analogues of amino acids in which the
carboxylic group is replaced by a phosphonic acid or related group (usually phosphonous or …
carboxylic group is replaced by a phosphonic acid or related group (usually phosphonous or …
Prospective of 68Ga-radiopharmaceutical development
I Velikyan - Theranostics, 2013 - pmc.ncbi.nlm.nih.gov
Positron Emission Tomography (PET) experienced accelerated development and has
become an established method for medical research and clinical routine diagnostics on …
become an established method for medical research and clinical routine diagnostics on …
Clinical applications of Gallium-68
Gallium-68 is a positron-emitting radioisotope that is produced from a 68Ge/68Ga generator.
As such it is conveniently used, decoupling radiopharmacies from the need for a cyclotron …
As such it is conveniently used, decoupling radiopharmacies from the need for a cyclotron …
Comparison of macrocyclic and acyclic chelators for gallium-68 radiolabelling
Gallium-68 (68Ga) is a positron-emitting isotope used for clinical PET imaging of peptide
receptor expression. 68Ga radiopharmaceuticals used in molecular PET imaging consist of …
receptor expression. 68Ga radiopharmaceuticals used in molecular PET imaging consist of …
Tumour targeting with radiometals for diagnosis and therapy
Use of radiometals in nuclear oncology is a rapidly growing field and encompasses a broad
spectrum of radiotracers for imaging via PET (positron emission tomography) or SPECT …
spectrum of radiotracers for imaging via PET (positron emission tomography) or SPECT …
Past, present and future of 68Ge/68Ga generators
F Rösch - Applied Radiation and Isotopes, 2013 - Elsevier
68Ga represents one of the very early radionuclides applied to positron emission
tomography (PET) imaging at a time when even the wording PET itself was not established …
tomography (PET) imaging at a time when even the wording PET itself was not established …
The renaissance of the 68Ge/68Ga radionuclide generator initiates new developments in 68Ga radiopharmaceutical chemistry
F Roesch, P J. Riss - Current topics in medicinal chemistry, 2010 - benthamdirect.com
68Ge/68Ga radionuclide generators have been investigated for almost fifty years now, since
the cyclotronindependent availability of positron emitting 68Ga via the 68Ge/68Ga system …
the cyclotronindependent availability of positron emitting 68Ga via the 68Ge/68Ga system …
Bifunctional gallium-68 chelators: Past, present, and future
P Spang, C Herrmann, F Roesch - Seminars in nuclear medicine, 2016 - Elsevier
This article reviews the development of bifunctional chelates for synthesising 68 Ga
radiopharmaceuticals. It structures the chelates into groups of macrocycles …
radiopharmaceuticals. It structures the chelates into groups of macrocycles …